Bellevue Group AG

Q3 2020 13F Holdings Report, Stock Holdings

Signature - Title
Christoph Eisenring / Michael Hutter - Head Legal & Compliance / CFO
Location
Kuesnacht
Holdings as of
September 30, 2020
Value $
$7.23B
Num holdings
216
Date filed
11/16/2020, 03:23 PM
Form type
13F-HR
Description
All US holdings of this investor are reported in this report. Top holdings included IONS, NBIX, INCY, VRTX, and ARGX.
Previous filing
Q2 2020 - Aug 13, 2020
Sym Weight Trade Impact Company Class Shares Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2020 Q3 compared to 2020 Q2 by default.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Christoph Eisenring / Michael Hutter Head Legal & Compliance / CFO Kuesnacht, Switzerland 11/13/2020

Other Included Managers (3):

Num Name Location File Number
1 Bb Biotech Ag Schaffhausen, Switzerland 28-06964
2 Bellevue Asset Management AG Kuesnacht, Switzerland 28-16892
3 Bellevue Asset Management (UK) Ltd. London, United Kingdom